Charu Aggarwal, MD, MPH, discusses treating patients with EGFR-mutant non–small cell lung cancer.
Uncommon Mutations in NSCLC
Joshua K. Sabari, MD, discusses the importance of timely testing for uncommon mutations in non–small cell lung cancer.
Nicholas C. Rohs, MD, discusses databases of uncommon mutations in non–small cell lung cancer
Advertisement
Advertisement
Trending on OncLive
1
BI-1808 Shows Efficacy as Monotherapy and in Combination With Pembrolizumab in T-Cell Lymphomas
2
Real-World Mogamulizumab Elicits Durable Responses in Pretreated Mycosis Fungoides and Sézary Syndrome
3
FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma
4
CHMP Recommends Pirtobrutinib for EU Approval in CLL Across All Lines of Therapy
5